Influencer Marketing in Finding New Patients

Boehringer Ingelheim acquired a new indication for their drug and approached us to spread awareness. Discover how we found 15 new scleroderma patients in just 5 months.

Client

Boehringer Ingelheim

Target Group

General public

Project Type

Awareness

Find out more

Challenge

"Scleroderma (systemic sclerosis) is a rare systemic disease affecting the skin, internal organs, joints, and muscles. While it's a complex disease with a varied course and no complete cure, early diagnosis and symptom control can keep it in check.

 Finding patients with a rare disease is always challenging (prevalence 100–300 people in Slovakia). You can either launch a wide-scale campaign or analyze data and facts to narrow down your target. As always, we chose the latter." — Darina Telepovská, Content Lead

Solution

Scleroderma affects women more often, and one of its first symptoms is Raynaud's phenomenon, which causes finger discoloration. Our team devised a plan to complement the classic digital campaign with influencer marketing: women would use photos of their manicures to raise disease awareness. They'd also encourage others to spread the idea using the hashtag #nanechtemalovane (painted on the nail).

We enhanced the campaign with our standard educational articles, social media ads, collaborations with patient organizations, and PR articles.

laptop a instagram (posty o sklerodermii)

Result

We reached 530,700 people, with over 11,000 visiting the website to learn about the disease.

306 people accessed the list of specialists.

15 newly diagnosed patients were identified.

Year-on-year product sales increased by 42%.

Social media impact: Over 32,000 people viewed Kristina Tormová's video, and over 39,000 watched Sisa_kr's video.

"Influencer marketing in healthcare isn't typically suitable, but we had a unique symptom that could be creatively presented. The enthusiastic engagement, positive feedback, and results proved it was the right move. Combined with a classic PPC campaign and PR, we ultimately identified 15 new patients."

— Darina Telepovská, Content Lead